Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045329 · ClinicalTrials.gov registry record
Impact of Mupirocin Decolonization on the Nasal Microbiome
A clinical trial, sponsored by VA Eastern Colorado Health Care System.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02045329 is a clinical trial that was terminated before completion, run by VA Eastern Colorado Health Care System. The registered enrollment target is 1 participants.
The verdict
NCT02045329 was terminated before completion, sponsored by VA Eastern Colorado Health Care System.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The normal bacteria that inhabit the human nose, also known as the nasal microbiome, may serve as a host defense mechanism against colonization and infection by Staphylococcus aureus, including methicillin resistant S. aureus (MRSA). Mupirocin is a topical antibacterial agent that may be used to clear nasal colonization with S. aureus, and reduce risk of S. aureus infection. The impact of mupirocin on the normal nasal microbiome is not known. We hypothesize that the nasal microbiome is changed by mupirocin. Our study aims to define the nasal microbiome before and after decolonization therapy with mupirocin.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-06-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02045329
The ClinicalTrials.gov registry entry for NCT02045329 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Eastern Colorado Health Care System, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02045329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02045329 about?
NCT02045329 is a clinical study titled "Impact of Mupirocin Decolonization on the Nasal Microbiome". The normal bacteria that inhabit the human nose, also known as the nasal microbiome, may serve as a host defense mechanism against colonization and infection by Staphylococcus aureus, including methicillin resistant S. aureus (MRSA). Mupirocin is a topical antibacterial agent that may be used to cle...
What is the current status of trial NCT02045329?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2013-10. Estimated completion is 2015-06-05.
Who is sponsoring clinical trial NCT02045329?
This trial is sponsored by VA Eastern Colorado Health Care System, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.